Royalty Pharma Plc (RPRX) — Capital Reinvestment Ratio
Royalty Pharma Plc (RPRX) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($702.62 Million) in capital expenditures ($1.11 Million). See RPRX net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Royalty Pharma Plc Capital Reinvestment Ratio (2002–2023)
This chart tracks Royalty Pharma Plc's Capital Reinvestment Ratio across 8 annual periods. Check RPRX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Royalty Pharma Plc (2002–2023)
Year-by-year Capital Reinvestment Ratio for Royalty Pharma Plc from 2002 to 2023. For live market cap and broader valuation context, see Royalty Pharma Plc (RPRX) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.71x | $2.99 Billion | $2.12 Billion | ▼ -25.6% |
| 2022 | 0.95x | $2.14 Billion | $2.04 Billion | ▲ +367160.5% |
| 2021 | 0.00x | $2.02 Billion | $523.00K | ▼ -100.0% |
| 2020 | 1.08x | $2.03 Billion | $2.20 Billion | ▲ +4.6% |
| 2019 | 1.03x | $1.67 Billion | $1.72 Billion | ▲ +519.7% |
| 2018 | 0.17x | $1.62 Billion | $269.59 Million | ▼ -89.7% |
| 2017 | 1.62x | $1.42 Billion | $2.29 Billion | ▲ +27735.6% |
| 2002 | 0.01x | $8.45 Million | $49.00K | — |